Jay Chol Choi , MD, PhD, Min Uk Jang , MD, Kyusik Kang , MD, Jong‐Moo Park , MD, PhD, Youngchai Ko , MD, PhD, Soo‐Joo Lee , MD, PhD, Jae‐Kwan Cha , MD, PhD, Dae‐Hyun Kim , MD, PhD, Sang Soon Park , MD, Tai Hwan Park , MD, PhD, Kyung Bok Lee , MD, PhD, Jun Lee , MD, PhD, Joon‐Tae Kim , MD, PhD, Ki‐Hyun Cho , MD, PhD, Kyung‐Ho Yu , MD, PhD, Mi‐Sun Oh , MD, PhD, Byung‐Chul Lee , MD, PhD, Yong‐Jin Cho , MD, PhD, Dong‐Eog Kim , MD, PhD, Ji Sung Lee , PhD, Juneyoung Lee , PhD, Philip B. Gorelick , MD, MPH, FACP, Hee‐Joon Bae , MD, PhD
9 January 2015
One third of patients presenting with initially mild strokes have unfavorable outcomes, and the efficacy of intravenous thrombolysis (IVT) in this population has not been proven. This study aimed to evaluate the comparative effectiveness of standard care with IVT versus without IVT in mild stroke patients.
Using a multicenter stroke registry database, we identified patients with acute ischemic stroke who presented within 4.5 hours of symptom onset and had initial National Institutes of Health Stroke Scale scores ≤5. Multivariable logistic analysis and propensity score matching were used to adjust for baseline imbalances between the patients who did and did not receive IVT. Adjusted odds ratios and 95% CIs of IVT were estimated for 3‐month modified Rankin Scale scores of 0 to 1 and symptomatic. Of 13 117 patients with stroke who were hospitalized between April 2008 and May 2012, 1386 met the eligibility criteria, and 194 (14.0%) were treated with IVT. For a modified Rankin Scale of 0 to 1 at 3 months, the adjusted odds ratios were 1.96 (95% CI, 1.28 to 3.00; P=0.002) by multivariable logistic analysis and 1.68 (1.10 to 2.56; P=0.02) by propensity score matching analysis, respectively. There was a statistically nonsignificant excess of symptomatic hemorrhagic transformation (odds ratios=3.76 [0.95 to 16.42; P=0.06] and 4.81 [0.84 to 49.34; P=0.09]), respectively.